IBB (Nasdaq Biotechnology) Stock Analysis - Insider Trades

Nasdaq Biotechnology (IBB) is a publicly traded the market company. As of May 20, 2026, IBB trades at $167.69 with a market cap of $0 and a P/E ratio of 0.00. IBB moved +2.20% today. Year to date, IBB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading IBB stock inside the company?

Rallies tracks IBB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

IBB Key Metrics

Key financial metrics for IBB
MetricValue
Price$167.69
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume1.77M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest IBB News

IBB Analyst Consensus

IBB analyst coverage data. Average price target: $0.00.

Common questions about IBB

Who is trading IBB stock inside the company?
Rallies tracks IBB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for IBB?
Yes. Rallies tracks IBB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IBB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBB. It does not provide personalized investment advice.
IBB

Nasdaq Biotechnology